RCT · 2026
What people said the day after psilocybin linked to staying off alcohol at 3 months
- Original title
- Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.
- Authors
- Garcia Garcia M, Belahda D, Graux C, et al.
- Journal
- Journal of affective disorders, 2026
- Molecules
- Psilocybin
- Conditions
- Alcohol use disorder, Depression
- Participants
- 20
- Evidence grade
- Low
- Source
- Read the original paper
The question
Do the things people say the day after a psilocybin session predict whether they stay off alcohol three months later?
What they did
Researchers looked at the first “integration” interview — a guided talk to make sense of the experience — held the day after dosing in a randomized trial called Psilocybin Alcohol Depression (PAD). Only the 20 participants given 25 mg of psilocybin were included. All had alcohol use disorder with ongoing depressive symptoms and had recently been through detox. Interview transcripts were analyzed with text-analysis software that sorts language into themes, and these themes were compared with whether people were abstinent at three months.
What they found
Of the 20 participants (55% male, median age 49), 55% were abstinent at three months. The transcripts totalled 127,760 words, and 88% of the text fell into two themes. One theme (44% of text segments) covered sensory and emotional descriptions — physical sensations, visuals, emotions, the setting — and came mostly from people who were not abstinent later. The other theme (56%) covered active thinking and inner dialogue, such as rethinking habits and committing to change. Abstinence at three months was significantly associated with talk of family connections, pleasant emotions, working through fear, and revisiting drinking triggers with new coping plans; non-abstinence was associated with negative emotions, physical pain, disappointment, and pushing feelings away.
The fine print
Only 20 people were analyzed, all from the active psilocybin arm, so there is no comparison with placebo and the findings cannot show what psilocybin itself caused. The links between what people said and later abstinence are associations found after the fact, and could reflect who was already more likely to succeed. Follow-up was three months, and abstinence reporting details are not given in the abstract. This summary is based on the abstract only.
What it means
How people talk about a psilocybin session the next day may signal how they are doing months later, which points to the possible value of preparation and follow-up conversations — but this small, uncontrolled analysis cannot prove that inner dialogue drives the outcome.
Evidence grade: Low. A small secondary analysis of interviews from just one arm of a randomized trial, with 20 people and outcomes compared after the fact rather than by randomized group.
This summary is based on the study’s published abstract.